NCT07537946 2026-04-17
Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer
Tongji Hospital
Phase 3 Not yet recruiting
Tongji Hospital
Qilu Pharmaceutical Co., Ltd.
Tempest Therapeutics
Changchun GeneScience Pharmaceutical Co., Ltd.
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.